We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted
in six countries. Economic data were collected over a 6-month period and presented from the
societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct
costs totalled about 60% to 70% and indirect costs about 30% to 40% of total costs. The proportions
of costs components of PD vary notably; variations were due to differences in country-specific
health system characteristics, macro economic conditions, as well as frequencies of resource use